Similar Clinical and Surgical Outcomes Achieved with Early Compared to Late Anti-TNF Induction in Mild-to-Moderate Ulcerative Colitis: A Retrospective Cohort Study

Background. Biologic agents targeting tumor necrosis factor alpha are effective in the management of ulcerative colitis (UC), but their use is often postponed until after failure of other treatment modalities. Objectives. We aim to determine if earlier treatment with infliximab or adalimumab alters...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Christopher, Beilman, Candace L., Huang, Vivian W., Fedorak, Darryl K., Wong, Karen, Kroeker, Karen I., Dieleman, Levinus A., Halloran, Brendan P., Fedorak, Richard N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958475/
https://www.ncbi.nlm.nih.gov/pubmed/27478817
http://dx.doi.org/10.1155/2016/2079582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958475/
https://www.ncbi.nlm.nih.gov/pubmed/27478817
http://dx.doi.org/10.1155/2016/2079582

Ejemplares similares